Pacific Biosciences of California, Inc. (PACB) earnings
PACB earnings moved a median of -1.11% by the close. Quarterly and annual PACB reports and results, each read against the price at its own news timestamp. Back to the PACB overview →
31 measured PACB earnings events.
Where these PACB earnings landedvs 31 measured PACB earnings reactions
| Middle 50% of PACB earnings reactions | -5.65% to +4.21% |
|---|---|
| Median reaction (to close) | -1.11% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 PACB earnings events with a measured close landed between -5.65% and +4.21%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PACIFIC BIOSCIENCES OF For: Jun 30 | SEC filing · Form 10-Q | -0.85% | +0.42% | |
| PacBio Announces Second Quarter 2026 Financial Results | Press release | -4.20% | -11.07% | |
| PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026 | Press release | +0.33% | -1.32% | |
| Form 10-Q PACIFIC BIOSCIENCES OF For: Mar 31 | SEC filing · Form 10-Q | +3.24% | -2.52% | |
| PacBio Announces First Quarter 2026 Financial Results | Press release | -2.67% | -7.24% | |
| PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 | Press release | +1.81% | +1.81% | |
| Form 10-K PACIFIC BIOSCIENCES OF For: Dec 31 | SEC filing · Form 10-K | +2.13% | +8.54% | |
| Form 10-Q PACIFIC BIOSCIENCES OF For: Sep 30 | SEC filing · Form 10-Q | -3.16% | +1.15% | |
| PacBio Announces Third Quarter 2025 Financial Results | Press release | +7.58% | -1.11% | |
| PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 | Press release | -0.27% | +6.56% | |
| Form 10-Q PACIFIC BIOSCIENCES OF For: Jun 30 | SEC filing · Form 10-Q | -3.08% | -7.53% | |
| PacBio Announces Second Quarter 2025 Financial Results | Press release | -3.08% | -7.53% | |
| PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025 | Press release | +2.06% | +10.96% | |
| Form 10-Q PACIFIC BIOSCIENCES OF For: Mar 31 | SEC filing · Form 10-Q | +0.45% | +2.68% | |
| PacBio Announces First Quarter 2025 Financial Results | Press release | +0.42% | -5.88% | |
| PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million | Press release | -0.74% | +7.41% | |
| Form 10-K PACIFIC BIOSCIENCES OF For: Dec 31 | SEC filing · Form 10-K | +1.63% | +0.81% | |
| PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025 | Press release | +0.00% | -3.75% | |
| Form 10-Q PACIFIC BIOSCIENCES OF For: Sep 30 | SEC filing · Form 10-Q | +4.30% | -9.63% | |
| PacBio Announces Third Quarter 2024 Financial Results | Press release | +11.01% | +5.50% | |
| PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024 | Press release | +0.97% | +27.74% | |
| Form 10-Q PACIFIC BIOSCIENCES OF For: Jun 30 | SEC filing · Form 10-Q | -0.63% | -2.45% | |
| PacBio Announces Second Quarter 2024 Financial Results | Press release | +10.43% | +20.14% | |
| PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024 | Press release | +1.78% | +31.82% | |
| Form 10-Q PACIFIC BIOSCIENCES OF For: Mar 31 | SEC filing · Form 10-Q | +5.23% | +2.91% | |
| PacBio Announces First Quarter 2024 Financial Results | Press release | +5.23% | +2.91% | |
| PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance | Press release | +1.44% | -28.20% | |
| Form 10-K PACIFIC BIOSCIENCES OF For: Dec 31 | SEC filing · Form 10-K | +0.96% | -3.66% | |
| PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024 | Press release | +0.28% | -2.63% | |
| Form 10-Q PACIFIC BIOSCIENCES OF For: Sep 30 | SEC filing · Form 10-Q | -2.78% | -5.42% | |
| PacBio Announces Third Quarter 2023 Financial Results | Press release | -0.82% | -8.17% |
Keep exploring
More PACB: analyst actions → · SEC filings → · PACB overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BOVIE MEDICAL (BVX) | 441 | 0.00% | 46% |
| Catalyst Pharmaceuticals, Inc. (CPRX) | 441 | 0.00% | 50% |
| EyePoint, Inc. (EYPT) | 439 | -0.25% | 46% |
| Abeona Therapeutics Inc. (ABEO) | 438 | +0.09% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.